Tianjin Pharmaceutical Da Ren Tang (SGX:T14) intends to sign a warehousing and logistics cooperation deal with Taiping Medicine for around 19 million yuan, according to a Friday Singapore bourse filing.
The traditional Chinese medicine maker's proposed arrangement will run until June 30, 2028, and will replace an expiring warehousing agreement, aimed to lowering transport costs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.